A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression ...

"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

A new clinical trial has shown promising results for cancer patients who no longer benefit from the most common treatment ...

Shares of Legend Biotech rose more than 40% Tuesday—on pace for the stock's biggest percentage increase on record—after the ...

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has ...

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

​In a clinical trial, daxaronrasib demonstrated a median overall survival of 13.2 months, compared with 6.7 months for ...

A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.

Preview this article 1 min The histrotripsy procedure uses precise ultrasound pulses to break down liver tumors in a single ...